Cargando…
Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans
Effective immunotherapy for cancer depends on cellular responses to tumor antigens. The role of major histocompatibility complex (MHC) in T-cell recognition and T-cell receptor repertoire selection has become a central tenet in immunology. Structurally, this does not contradict earlier findings that...
Autores principales: | Pashov, Anastas, Monzavi-Karbassi, Bejatolah, Raghava, Gajendra P. S., Kieber-Emmons, Thomas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896669/ https://www.ncbi.nlm.nih.gov/pubmed/20617150 http://dx.doi.org/10.1155/2010/354068 |
Ejemplares similares
-
Tumor-Associated Glycans and Immune Surveillance
por: Monzavi-Karbassi, Behjatolah, et al.
Publicado: (2013) -
Carbohydrate Mimetic Peptides Augment Carbohydrate-Reactive Immune Responses in the Absence of Immune Pathology
por: Hennings, Leah, et al.
Publicado: (2011) -
Carbohydrate-Mimetic Peptides for Pan Anti-Tumor Responses
por: Kieber-Emmons, Thomas, et al.
Publicado: (2014) -
The promise of the anti-idiotype concept
por: Kieber-Emmons, Thomas, et al.
Publicado: (2012) -
Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects
por: Hutchins, Laura F., et al.
Publicado: (2017)